Detalles de la búsqueda
1.
Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis.
Am J Hum Genet
; 109(8): 1484-1499, 2022 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35896117
2.
Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19.
Transpl Int
; 37: 12360, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596505
3.
Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study.
Transpl Int
; 37: 11571, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38694490
4.
Nonskeletal and skeletal effects of high doses versus low doses of vitamin D3 in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial.
Am J Transplant
; 23(3): 366-376, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695682
5.
Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial.
Am J Transplant
; 22(5): 1430-1441, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990047
6.
Diagnosis and risk factors for intracranial aneurysms in autosomal polycystic kidney disease: a cross-sectional study from the Genkyst cohort.
Nephrol Dial Transplant
; 37(11): 2223-2233, 2022 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35108395
7.
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International.
Nephrol Dial Transplant
; 37(5): 825-839, 2022 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35134221
8.
HEMO2 life® improves renal function independent of cold ischemia time in kidney recipients: A comparison with a large multicenter prospective cohort study.
Artif Organs
; 46(4): 597-605, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951495
9.
Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.
Am J Hum Genet
; 102(5): 832-844, 2018 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29706351
10.
Among CMV-positive renal transplant patients receiving non-T-cell depleting induction, the absence of CMV disease prevention is a safe strategy: A retrospective cohort of 372 patients.
Transpl Infect Dis
; 23(3): e13541, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33270341
11.
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants.
Kidney Int
; 98(6): 1549-1558, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32853631
12.
Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease.
Kidney Int
; 98(2): 476-487, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631624
13.
First-in-human use of a marine oxygen carrier (M101) for organ preservation: A safety and proof-of-principle study.
Am J Transplant
; 20(6): 1729-1738, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012441
14.
Uromodulin processing in DNAJB11-kidney disease.
Kidney Int
; 105(2): 376-380, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38016513
15.
Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Am J Hum Genet
; 98(6): 1193-1207, 2016 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27259053
16.
Novel long-range regulatory mechanisms controlling PKD2 gene expression.
BMC Genomics
; 19(1): 515, 2018 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29986647
17.
Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8.
Am J Physiol Renal Physiol
; 315(1): F57-F73, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29537311
18.
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.
Nephrol Dial Transplant
; 33(4): 645-652, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28992127
19.
[Polycystic kidney disease: diagnosis and progressive profile, prognostic elements]. / Polykystose rénale autosomique dominante : diagnostic, profil évolutif, éléments pronostiques.
Rev Prat
; 68(5): 559-563, 2018 May.
Artículo
en Francés
| MEDLINE | ID: mdl-30869430
20.
PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
Am J Kidney Dis
; 70(4): 476-485, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28356211